Exercise tolerance as a guide to therapeutic efficacy for heart failure - The potential for angiotensin receptor blockers

被引：2
作者：
Cohn, JN [1 ]
机构：
[1] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA
来源：
CIRCULATION | 1999年 / 100卷 / 22期
关键词：
editorials; exercise; heart failure;
D O I：
10.1161/01.CIR.100.22.2208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2208 / 2209
页数：2
相关论文
共 15 条
[11]  
Narang R, 1996, EUR HEART J, V17, P120
[12]  
Packer M, 1999, AM J CARDIOL, V83, p1A
[13]   Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II [J].
Pitt, B ;
Poole-Wilson, P ;
Segal, R ;
Martinez, FA ;
Dickstein, K ;
Camm, AJ ;
Konstam, MA ;
Riegger, G ;
Klinger, GH ;
Neaton, J ;
Sharma, D ;
Thiyagarajan, B .
JOURNAL OF CARDIAC FAILURE, 1999, 5 (02) :146-154
[14]  
Rector TS, 1987, HEART FAILURE, V3, P198, DOI DOI 10.1177/1474515111435605
[15]   Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil [J].
Riegger, GAJ ;
Bouzo, H ;
Petr, P ;
Münz, J ;
Spacek, R ;
Pethig, H ;
von Behren, V ;
George, M ;
Arens, HJ .
CIRCULATION, 1999, 100 (22) :2224-2230
12